It’s human nature to want to know what’s coming. It seems fitting, then, that our IP & Science business, with innovation at its core, should also partake in leveraging its assets to forecast the future. The following is one prediction from our new report that features 10 innovation predictions for the world in 2025. Make sure to check out the entire series of posts and download the full report here.
A versatile human genome engineering platform is a reality, paving the way for the modification of disease-causing genes and helping to prevent certain metabolic conditions.
Like type 2 diabetes, type 1 diabetes and other metabolic conditions such as muscular dystrophy will be preventable in 2025, but not by diet and exercise. Advancements in ribonucleic acid-guided (RNA-guided) engineering used for specialist sequence synthesis will be so much more sophisticated that a human genome engineering platform will exist. The pillar biological molecules of life on earth: RNA, DNA and proteins, and the roles they play, will be understood much more clearly in the next decade.
The in-depth operations of RNA, the main pathways from DNA to proteins, and proteins, the cell’s worker bees that carry out various catalytic and structural functions, will be demystified. The RNA/DNA process of passing inherited genetic information from one generation to the next will be clear. Increased knowledge of these biological pillars will make genomic-editing-and-repairing DNA a reality in humans, not just in bacteria and mice.
Also a reality will be the patenting of organisms and partial DNA segments, thereby complicating the landscape of who owns rights to what and where the line between nature and commerce exists. The human genome engineering platform will pave the way for the modification of disease-causing genes in humans, leading to the prevention of type I diabetes, among other ailments.
Download the full report: The World in 2025: 10 Predictions of Innovation